Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-20
    E.g., 2018-09-20

Archive Search

1 results
10:21 AM, Apr 13, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Abpro planning $69M NASDAQ listing

to develop it to treat HER2-positive solid tumors in Orphan indications. ABP-201 targets VEGF and angiopoietin 2
ANG2; ANPT2). The company intends to develop that antibody to treat vascular diseases of the eye …